The Science & Research team at Prelude Therapeutics is responsible for discovering and developing novel drug candidates that target essential cancer cell pathways. Comprising experts in chemistry, biology, drug discovery, translational research, and process chemistry, the team collaborates to advance the company's precision oncology pipeline from conceptualization through clinical development.
Andrew Buesking
Director, Chemistry
Andrew Combs
EVP & Head of Chemistry
Bo Shen
Director, Process Chemistry
Diane Heiser
Vice President, Translationl R...
Ganfeng Cao 曹敢峰
Vice President And Head Of Pro...
Joe Rager
Director, Drug Metabolism And ...
Kenneth Ray
Director, Analytical Chemistry
Koichi Ito
Director Biology
Sandy Geeganage
Vice President - Drug Discover...
Sang Hyun Lee
Vice President Of Biology
View all